Novo Nordisk's product recalls
2 official recall notices between Jan 2026 and Jan 2026 were matched to Novo Nordisk and brands it owned at the time, including Wegovy.
Each notice concerns the specific products, sizes and lot codes it names. A recall does not mean that other Novo Nordisk products are affected, and a count of notices is not a measure of safety: one incident can produce a notice for every pack size.
Covers only notices from the U.S. Food and Drug Administration enforcement reports (openFDA), USDA Food Safety and Inspection Service recalls, UK Food Standards Agency food alerts and U.S. Consumer Product Safety Commission recalls that could be matched to Novo Nordisk: the recalling firm must be Novo Nordisk, a parent or a subsidiary, and for a brand the brand name must appear in the product description. Method.
2026 (2)
| Date | Product | Brand | Recalling firm | Reason given | Source |
|---|---|---|---|---|---|
| Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of… | Wegovy | Novo Nordisk Inc. | Presence of Particulate Matter: Hair was found in a prefilled syringe Class II | FDA | |
| Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark,… | Wegovy | Novo Nordisk Inc. | Presence of Particulate Matter: Hair was found in a prefilled syringe Class II | FDA |
Product descriptions and reasons are shortened from the regulators' own text; the linked notice is the authoritative record. See all matched recalls, or report a wrong match through the corrections page.